Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/1/1988


1.		Phase III Randomized, Placebo-Controlled Study of Beta-Carotene and Vitamin E in the Prevention of Lung Cancer (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				50 to 69								DCPC-CPSB-10005

Last Modified: 10/1/1988


2.		Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				40 to 69								DCPC-CPSB-11204

Last Modified: 8/1/1990


3.		Phase III Study of Radiotherapy Alone vs Radiotherapy plus Oral Beta-Carotene in Patients with Advanced Cancer of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				any age								UCHSC-88251 NCI-V89-0098

Last Modified: 8/1/1993


4.		Phase III Randomized Placebo-Controlled Study of Beta Carotene for Chemoprevention of Second Primaries in Patients with Stage I/II Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				adult				NCI				SWOG-9043 NCI-P93-0039

Last Modified: 1/1/1990


5.		Phase II Study of Isotretinoin (Ro4-3780) with Randomization to Isotretinoin or Beta Carotene Treatment in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 01/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				15 and over								MDA-DM-87017 NCI-P89-0001

Last Modified: 11/1/1992


6.		Phase II Study of Beta Carotene with Randomization to No Treatment or Beta Carotene Maintenance in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 11/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				18 and over								UARIZ-8979 NCI-P92-0012

Last Modified: 9/5/2008


7.		Phase II, Randomized, Placebo-controlled Study of Beta-Carotene for Chemoprevention of Premalignant Cervical Cancer (Summary Last Modified 06/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				21 to 60				NCI				UCI-90146 NCI-P92-0016


8.		Safety of Antioxidants During GYN Cancer Care

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				No age specified				Other				10006 NCT00284427

Last Modified: 11/9/2007


9.		Randomized, Placebo-Controlled Study of Beta Carotene, Vitamin E, and Aspirin for Chemoprevention of Cancer and Cardiovascular Disease in Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				45 and over				NCI, NHLBI				BWH-WHS BWH-1999-P-001304, BWH-2004-P-001661, BWH-88-02744, NCI-P92-0024, NCT00000479

Last Modified: 6/1/1993


10.		Randomized, Placebo-Controlled Study of Beta Carotene for Chemoprevention of Premalignant Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				16 to 65								AECM-CCI90-140 NCI-P92-0025

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute